Phytotherapy Research · 2004 · 197 citations · 18 references
Life SciencesMicrobiologyPlant SciencesAntimicrobial PharmacologyMycologyPlant-microbe InteractionsAntifungal AgentsAntifungal PharmacologyAntifungal TherapyEssential Oil PlantsFungal PathogenesisFungal Secondary MetabolitesAntifungal Combination TherapyAntifungal PharmacodynamicsBioactive Fungal MetabolitesCandida Albicans InfectionCandida TherapyEssential Oils As PreservativesFungal Bioactive CompoundsNatural Antifungal Compounds
The antifungal effect of the essential oil from Satureja montana L., Lavandula angustifolia Mill., Lavandula hybrida Reverchon, Syzygium aromaticum (L.) Merril and Perry, Origanum vulgare L., Rosmarinus officinalis L. and six chemotypes of Thymus vulgaris L. on Candida albicans growth were studied. The most efficiency was obtained with the essential oil from Thymus vulgaris thymol chemotype (MIC 80% = 0.016 microL/mL and Kaff = 296 microL/mL). The presence in the culture medium of essential oil from Thymus vulgaris thymol chemotype (0.01, 0.1, 0.2, 0.3 microg/mL) and amphotericin B involved a decrease of the MIC 80% of amphotericin B. In contrast, the combination of amphotericin B and low concentrations (0.00031-0.0025 microg/mL) of essential oil was antagonistic. The strongest decrease (48%) of the MIC 80% was obtained with medium containing 0.2 microL/mL of essential oil. These results signify that the essential oil of Thymus vulgaris thymol chemotype potentiates the antifungal action of amphotericin B suggesting a possible utilization of this essential oil in addition to antifungal drugs for the treatment of mycoses.
18
Antibacterial and Antifungal Properties of Essential Oil Components
Karl Knobloch, Alexander Pauli, B. Iberl et al. · Journal of Essential Oil Research · 1989 · 648 citations
Nephrotoxicity of Amphotericin B
William T. Butler · Annals of Internal Medicine · 1964 · 330 citations
Hans Christian Körting, Markus Ollert, A. Georgii et al. · Journal of Clinical Microbiology · 1988 · 183 citations · Full text